Clinical Trial Update: ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients

View source ↗

Summary

This completed clinical trial from Seoul National University Hospital compares ABO- or HLA-incompatible living-donor kidney transplantation (LDKT) to waitlist o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Kidney Transplantation

Snippet

Sponsor: Seoul National University Hospital | Conditions: Kidney Transplant, End Stage Kidney Disease (ESRD) | Status: COMPLETED